Skip to main content
. 2015 Jul 22;6(30):29285–29295. doi: 10.18632/oncotarget.4978

Table 1. Clinical and molecular pathology features between training and validation sets.

Characteristic Training set
(N=75)
Validation set
(N=75)
P-value
Gender 1.0000*
 Male 38 (51%) 385 (51%)
 Female 37 (49%) 37 (49%)
Age, years 0.1218†
 Mean (range) 58.5 (10.9-85.2) 56.5 (19-85.6)
Age, per 20 years 0.3637*
 <30 3 3
 30-49 16 17
 50-69 34 42
 ≥70 22 13
KPS 0.8412*
 ≥80 37 (67%) 42 (70%)
 <80 18 (33%) 18 (30%)
IDH1 mutation 0.6091*
 Mutation 7 (11%) 10 (15%)
 Wild type 55 (89%) 57 (85%)
Radiation 1.0000*
 Yes 71 71
 No 4 4
Chemotherapy 0.5408*
 Yes 62 58
 No 13 17

Data are mean n (%) or otherwise stated.

*

χ2 test or Fisher's exact test, †Student's t-test.